Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Canbay

Showing results (71-80 of 327) with videos related to

Pageof 33
Sort By:
Medicine|February 4, 2022
ERCP in critically ill patients is safe and does not increase mortalityMatthias Buechter, Antonios Katsounas, Fuat Saner, et al.
Zeitschrift Fur Gastroenterologie|March 17, 2021
[Chronic kidney injury in patients with liver diseases - Reappraising pathophysiology and treatment options]Florian Gunnar Scurt, Katrin Bose, Ali Canbay, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|July 17, 2024
[When should a liver disease patient be admitted to the intensive care unit?]Eda Kaya, Patrick Nekarda, Isabella Traut, et al.
Gut|June 5, 2015
Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosisSotiria Bedreli, Jan-Peter Sowa, Guido Gerken, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicityHajime Higuchi, Steven F Bronk, Makiko Taniai, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Role of stress-induced NKG2D ligands in liver diseasesAlisan Kahraman, Christian D Fingas, Wing-Kin Syn, et al.
Clinical Chemistry and Laboratory Medicine|February 16, 2026
From ordering to interpretation: a comprehensive framework for laboratory test indicationsJasmin Weninger, Thomas Streichert, Abdurrahman Coskun, et al.
Digestion|March 18, 2021
Analysis of Ascites-Challenged Blood in Patients with Liver Cirrhosis Using Rotational Thromboelastometry: How Robust Is the Evidence on Ascites-Attributed Fibrinolysis?Sotiria Bedreli, Dimitrios Eleftheriadis, Michael Jahn, et al.
The Journal of Biological Chemistry|October 17, 2003
Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1Hajime Higuchi, Annette Grambihler, Ali Canbay, et al.
Nature Reviews. Gastroenterology & Hepatology|August 21, 2013
From NAFLD to NASH to cirrhosis-new insights into disease mechanismsAlexander Wree, Lori Broderick, Ali Canbay, et al.
Pageof 33

Showing results (71-80 of 327) with videos related to

Sort By:
Pageof 33
Medicine|February 4, 2022
ERCP in critically ill patients is safe and does not increase mortalityMatthias Buechter, Antonios Katsounas, Fuat Saner, et al.
Zeitschrift Fur Gastroenterologie|March 17, 2021
[Chronic kidney injury in patients with liver diseases - Reappraising pathophysiology and treatment options]Florian Gunnar Scurt, Katrin Bose, Ali Canbay, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|July 17, 2024
[When should a liver disease patient be admitted to the intensive care unit?]Eda Kaya, Patrick Nekarda, Isabella Traut, et al.
Gut|June 5, 2015
Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosisSotiria Bedreli, Jan-Peter Sowa, Guido Gerken, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicityHajime Higuchi, Steven F Bronk, Makiko Taniai, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Role of stress-induced NKG2D ligands in liver diseasesAlisan Kahraman, Christian D Fingas, Wing-Kin Syn, et al.
Clinical Chemistry and Laboratory Medicine|February 16, 2026
From ordering to interpretation: a comprehensive framework for laboratory test indicationsJasmin Weninger, Thomas Streichert, Abdurrahman Coskun, et al.
Digestion|March 18, 2021
Analysis of Ascites-Challenged Blood in Patients with Liver Cirrhosis Using Rotational Thromboelastometry: How Robust Is the Evidence on Ascites-Attributed Fibrinolysis?Sotiria Bedreli, Dimitrios Eleftheriadis, Michael Jahn, et al.
The Journal of Biological Chemistry|October 17, 2003
Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1Hajime Higuchi, Annette Grambihler, Ali Canbay, et al.
Nature Reviews. Gastroenterology & Hepatology|August 21, 2013
From NAFLD to NASH to cirrhosis-new insights into disease mechanismsAlexander Wree, Lori Broderick, Ali Canbay, et al.
Pageof 33